Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real World Zepatier in Hemodialysis HCV Patients
NCT03365635Phase 4Completed
- Sponsor
- University of Pennsylvania
- Start
- Sep 2019
- Primary completion
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of grazoprevir in hepatitis C (HCV), sponsored by University of Pennsylvania. Started Sep 2019; status: completed.
02
Drugs
grazoprevir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT03365635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03365635.